Dr Sandeep Kumar

leukemia cml imatinib resistance various mutations in cml chronic myeloid leukemia mutations in cml t315i tki resistance idsa dabigatran reversal neutropenia profound neutropenia febrile neutropenia fever anc cultutures nilotinib resistance posatinib philadelphia chromosome bcr-abl1 cytogenetics ph chromosome dasatinib resistance molecular biology nccn apl 2014 guidelines pathophysiology aspirin prexabind apixaban noacs parental anticoagulant drugs fondaparinaux predaxa vkas rivaroxaban recent advances in anticogulation dabigatran idarucizumab antiplatelet heparin atrial fibrillation esc doacs mrsa pseudomonas dialysis peritoneal dialysis pd hemodialysis alternate capd cost effective dialysis hyperkalemia refractory hyperkalemia prescription prescription writing safety prescribe medical medicine foundation course mbbs fy1 nhs transition to accelerated phase imatinib molecular basis of cml tki f317l mutation cml video graphics t315i mutation pathophysiology of cml treatment and drug sensitivity of cml mutations history of cml ats hap 2016 hcap pneumonia ats/idsa vap 2016 pneumonia guidelines acinetobacter cre